Spots Global Cancer Trial Database for Treatment of Disseminated High Grade Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Treatment of Disseminated High Grade Lymphoma
Official Title: Phase III Study of Treatment of Disseminated and Agressive Lymphoma R CHOP Versus R CLOP( With Liposomal Doxorubicin)
Study ID: NCT00536393
Conditions
Study Description
Brief Summary: Interest of the use of pegylated liposomal doxorubicin (caélyx)
Detailed Description: R CHOP is a good standard in the treatment of diffuse high grade lymphoma. Howeverin elderly patients it is often toxic, specially with haematologic and cardiac toxicities.
Eligibility
Minimum Age: 60 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Clinique Victor Hugo, Le Mans, , France
Contact Details
Name: Guillaume CARTRON, Dr
Affiliation: French Innovative Leukemia Organisation
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
